Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
1. Mr. Trump announced in November 2024 that Robert F. Kennedy Jr., son of former Attorney General Robert F. Kennedy and nephew to President John F. Kennedy, is his pick for HHS Secretary. Mr. Kennedy ...
Feature / In 2020, after losing his bid for reelection to Joe Biden, Donald Trump summoned a mob to the Capitol. Today, as we ...
A patriot and leader, Mr. Paul Mango touched the lives of many, leaving behind a tremendous legacy and an inspiring beacon for all fighting for a healthy America.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback